 of
disease severity, major adverse cardiovascular events and all-cause
mortality in patients with peripheral arterial disease. Vasc Med
2010;15:267-74.
26. Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY,
et al. Beta2-microglobulin as a biomarker in peripheral arterial disease:
proteomic proﬁling and clinical studies. Circulation